EGFR and hepatocellular carcinoma: Moreover, the protein 14‐3‐3σ is verified to enhance resistance to anoikis in HCC cells through the impeding the degradation of EGFR and modulating the stimulation of the EGFR‐mediated ERK1/2 signaling cascade [12].